tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - agenti antineoplastici - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
xalkori
pfizer europe ma eeig - crizotinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.
varisma s�duction kl aktiv collant at
laboratoires innothera - calze e gambali compressivi
varisma s�duction kl aktiv calza coscia ag
laboratoires innothera - calze e gambali compressivi
varisma comfort coton kkl iᄚ gambaletto
laboratoires innothera - calze e gambali compressivi
varisma comfort coton kkl iᄚ calza coscia ag
laboratoires innothera - calze e gambali compressivi
varisma comfort coton kkl iᄚ collant at
laboratoires innothera - calze e gambali compressivi
varisma comfort coton kkl iᄚ collant gestante atm
laboratoires innothera - calze e gambali compressivi